News BMS shakes up R&D under CMO Cristian Massacesi Bristol Myers Squibb is combining its R&D operations into a single unit led by chief medical officer and development head Cristian Massacesi.
News ViiV's Waterhouse exits to take the CEO job at CSL CSL has named Deborah Waterhouse as its new chief executive, on the same day her departure from the same role at ViiV was announced.
News Brent Saunders ejects from Bausch + Lomb once again Brent Saunders' second stint as chief executive of eye care company Bausch + Lomb has come to an end.
News European biotech leaders say optimism is returning Senior figures in European biopharma think dealmaking and M&A will increase in the region, and could be helped by US policy uncertainties.
News Bayer names Christoph Koenen as its new CMO Bayer has looked internally for its chief medical officer, appointing Christoph Koenen to the post alongside his current clinical development role.
News PhRMA hires ex-House Majority Leader Eric Cantor as its CEO Former Republican lawmaker Eric Cantor has been named as the new CEO of US pharma group PhRMA, replacing long-serving Stephen Ubl.
News Isomorphic adds MSD to partner roster, and other deals It's been a busy dealmaking week, with Isomorphic Labs, fresh from a $5 billion financing, adding MSD to its list of research alliances.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.